Low Grade Ovarian Serous Adenocarcinoma, Malignant Ovarian Neoplasm, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Psammocarcinoma
Conditions
Brief summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Detailed description
PRIMARY OBJECTIVES: I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for approximately 1600 female patients with low-grade ovarian and peritoneal tumors. II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome. III. To have a single data repository, kept on a secure platform that will integrate clinical information and research findings and serve as a secure archive for future research. SECONDARY OBJECTIVE: I. To obtain and store human tumor samples in the form of blocks or slides for the purpose of establishing a tumor bank. OUTLINE: Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.
Interventions
PROCEDUREBiospecimen Collection
Patients' residual tissue samples are collected
OTHERElectronic Health Record Review
Medical records are reviewed
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis: * Ovarian tumor of low malignant potential * Low-grade serous carcinoma of the ovary * Primary peritoneal tumor of low malignant potential * Low-grade serous carcinoma of the peritoneum * Psammocarcinoma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prospective and retrospective data collection on disease characterization, treatment, and outcomes | Up to 28 years | — |
| Organization of clinical information | Up to 28 years | Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome. |
| Creation of a single data repository to integrate clinical information and research findings | Up to 28 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Collection and storage of human tumor samples for the establishment of a tumor bank | Up to 28 years |
Countries
United States
Contacts
CONTACTLisa Nathan
PRINCIPAL_INVESTIGATORDavid M Gershenson
M.D. Anderson Cancer Center
Outcome results
None listed